755033-31-9Relevant academic research and scientific papers
Development of a synthetic route towards N4,N9-disubstituted 4,9-diaminoacridines: On the way to multi-stage antimalarials
Fonte, Mélanie,Fagundes, Natália,Gomes, Ana,Ferraz, Ricardo,Prudêncio, Cristina,Araújo, Maria Jo?o,Gomes, Paula,Teixeira, Cátia
, p. 1166 - 1169 (2019/03/27)
A multi-step synthetic route towards N4,N9-disubstituted 4,9-diaminoacridines that, to the best of our knowledge, has no precedence in the literature, has been developed. The target structures are likely to reveal interesting biological activities in the near future, not only due to their mepacrine-like core, but also because they embed simultaneously the pharmacophores of chloroquine and primaquine, antimalarial drugs that act at different stages of malaria infection.
Design, synthesis, and biological activity of 5,10-dihydro-dibenzo[b,e][1, 4]diazepin-11-one-based potent and selective Chk-1 inhibitors
Wang, Le,Sullivan, Gerard M.,Hexamer, Laura A.,Hasvold, Lisa A.,Thalji, Reema,Przytulinska, Magdalena,Tao, Zhi-Fu,Li, Gaoquan,Chen, Zehan,Xiao, Zhan,Gu, Wen-Zhen,Xue, John,Bui, Mai-Ha,Merta, Philip,Kovar, Peter,Bouska, Jennifer J.,Zhang, Haiying,Park, Chang,Stewart, Kent D.,Sham, Hing L.,Sowin, Thomas J.,Rosenberg, Saul H.,Lin, Nan-Horng
, p. 4162 - 4176 (2008/02/13)
A novel series of 5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-ones have been synthesized as potent and selective checkpoint kinase 1 (Chk1) inhibitors via structure-based design. Aided by protein X-ray crystallography, medicinal chemistry efforts led to the
HETEROCYCLIC KINASE INHIBITORS
-
Page 250, (2010/02/08)
Compounds having the formula (I) are useful for inhibiting protein kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
